The Role of Serum Adiponectin for Outcome Prediction in Patients with Dilated Cardiomyopathy and Advanced Heart Failure.

about

The Role of Serum Adiponectin for Outcome Prediction in Patients with Dilated Cardiomyopathy and Advanced Heart Failure.

Item

http://www.wikidata.org/entity/Q48275039

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The Role of Serum Adiponectin ...... hy and Advanced Heart Failure.

@en

The Role of Serum Adiponectin ...... hy and Advanced Heart Failure.

@nl

type

Item

label

The Role of Serum Adiponectin ...... hy and Advanced Heart Failure.

@en

The Role of Serum Adiponectin ...... hy and Advanced Heart Failure.

@nl

prefLabel

The Role of Serum Adiponectin ...... hy and Advanced Heart Failure.

@en

The Role of Serum Adiponectin ...... hy and Advanced Heart Failure.

@nl

P1476

The Role of Serum Adiponectin ...... hy and Advanced Heart Failure.

@en

P2093

Daiva Bironaitė

http://www.w3.org/2001/XMLSchema#string

Kęstutis Ručinskas

http://www.w3.org/2001/XMLSchema#string

Virginija Grabauskienė

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of Ankrd1 in Dilated Cardiomyopathy Correlates with the Heart Failure Progression

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

Adiponectin and adiponectin receptors

Determinants of adiponectin levels in patients with chronic systolic heart failure

Adiponectin is associated with increased mortality and heart failure in patients with stable ischemic heart disease: data from the Heart and Soul Study.

Cachexia in heart disease: highlights from the ESC 2010

Implications of plasma concentrations of adiponectin in patients with coronary artery disease.

Circulating adiponectin concentrations in patients with congestive heart failure.

Adipose tissue inflammation and adiponectin resistance in patients with advanced heart failure: correction after ventricular assist device implantation

P304

3818292

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/3818292

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-11-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29318144

http://www.w3.org/2001/XMLSchema#string

P932

5727561

http://www.w3.org/2001/XMLSchema#string